1. Home
  2. HYPD vs SFWL Comparison

HYPD vs SFWL Comparison

Compare HYPD & SFWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HYPD
  • SFWL
  • Stock Information
  • Founded
  • HYPD 2014
  • SFWL 2001
  • Country
  • HYPD United States
  • SFWL China
  • Employees
  • HYPD N/A
  • SFWL N/A
  • Industry
  • HYPD
  • SFWL Trucking Freight/Courier Services
  • Sector
  • HYPD
  • SFWL Industrials
  • Exchange
  • HYPD NYSE
  • SFWL Nasdaq
  • Market Cap
  • HYPD 73.3M
  • SFWL 81.0M
  • IPO Year
  • HYPD 2018
  • SFWL 2023
  • Fundamental
  • Price
  • HYPD $12.52
  • SFWL $1.00
  • Analyst Decision
  • HYPD
  • SFWL
  • Analyst Count
  • HYPD 0
  • SFWL 0
  • Target Price
  • HYPD N/A
  • SFWL N/A
  • AVG Volume (30 Days)
  • HYPD 6.5M
  • SFWL 9.3K
  • Earning Date
  • HYPD 08-11-2025
  • SFWL 09-04-2025
  • Dividend Yield
  • HYPD N/A
  • SFWL N/A
  • EPS Growth
  • HYPD N/A
  • SFWL 4.79
  • EPS
  • HYPD N/A
  • SFWL 0.13
  • Revenue
  • HYPD $67,063.00
  • SFWL $504,158,000.00
  • Revenue This Year
  • HYPD N/A
  • SFWL N/A
  • Revenue Next Year
  • HYPD N/A
  • SFWL N/A
  • P/E Ratio
  • HYPD N/A
  • SFWL $7.46
  • Revenue Growth
  • HYPD 663.82
  • SFWL 24.75
  • 52 Week Low
  • HYPD $0.85
  • SFWL $0.86
  • 52 Week High
  • HYPD $124.80
  • SFWL $1.60
  • Technical
  • Relative Strength Index (RSI)
  • HYPD N/A
  • SFWL 54.48
  • Support Level
  • HYPD N/A
  • SFWL $0.96
  • Resistance Level
  • HYPD N/A
  • SFWL $1.02
  • Average True Range (ATR)
  • HYPD 0.00
  • SFWL 0.05
  • MACD
  • HYPD 0.00
  • SFWL 0.00
  • Stochastic Oscillator
  • HYPD 0.00
  • SFWL 90.91

About HYPD HYPERION DEFI INC

Hyperion DeFi Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or new combinations.

About SFWL Shengfeng Development Limited

Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services.

Share on Social Networks: